No significant effect of GLP-1 receptor agonists identified on the risk of fatal or non-fatal myocardial infarction compared with the placebo controls (RR: 0.91; 95% CI: 0.82 – 1.01; P = 0.06). Here, GLP1R is linked to myocardial infarction.